Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Cellulaire en moleculaire mechanismen van hiv-1-overdracht
sep 2021 | HIV, Virale infecties